NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against The Toronto-Dominion Bank (NYSE: TD) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in TD Bank, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/the-toronto-dominion-bank. Investors have until December 23, 2024 to ask the Court to be ...

NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Zeta Global Holdings Corp. (NYSE: ZETA) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Zeta, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/zeta-global-holdings-corp. Investors have until January 21, 2025, to ask the Court to be ...

NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) --  Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Chipotle Mexican Grill, Inc. (NYSE: CMG) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Chipotle, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/chipotle-mexican-grill-inc. Investors have until January 10, 2025, to ask the Cour ...

NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Edwards Lifesciences Corporation (NYSE:EW) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Edwards Lifesciences, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/edwards-lifesciences-corporation. Investors have until December 13, 2 ...

NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) --  Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against PACS Group, Inc. (NYSE: PACS) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in PACS, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/pacs-group-inc. Investors have until January 13, 2025, to ask the Court to be appointed to lead ...

After a few months of weakening data, home sales reports finally ticked higher, giving investors new hope for a rebound in the real estate sector. However, there is no reason to start celebrating yet, as other factors and themes need to fall back into line before the skies are clear for the industry. One month of positive data isn’t enough to erase quarters of contraction. Be that as it may, it doesn’t mean that nobody could come out a winner from this situation, as there is a more significant trend behind ...

Google is in trouble. As my colleague Dan Milmo reported, the US Department of Justice “has proposed a far-reaching overhaul of Google’s structure and business practices, including the sale of its Chrome browser, in a bid to end its monopoly on internet search”. The move follows a major court ruling last August in which a federal judge determined that Google had violated antitrust laws and held an illegal monopoly over search services. The justice department’s suggestion is blunt: “Google must divest Chrome ...

The Nasdaq-100 index tracks the largest 100 non-financial companies on the Nasdaq stock exchange. Although it's not a part of the U.S. stock market's big three indexes (S&P 500, Nasdaq Composite, and Dow Jones), the Nasdaq-100 has grown in popularity over the years because of its concentration of tech stocks (almost 60%), many of which have seen their valuations skyrocket in recent years.Through Nov. 22, the Nasdaq-100 is up over 23%, which is impressive for a broad index. However, it hasn't been peachy kee ...

Record third quarter net sales of $1.2 billion, up 14% from last year with comparable sales of 16%Broad-based net sales growth across regions and brands, with Abercrombie brands growth of 15% and Hollister brands growth of 14%Operating margin expands 170 basis points to 14.8%, with third quarter operating income increasing 30% to $179 millionYear-to-date, repurchased 924,000 shares for $130 million, representing 1.8% of shares outstanding at February 3, 2024Increases full year outlook to net sales growth of ...

•  First marketing authorization submission for blarcamesine NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) diseases, today announced the submission of the blarca ...